A plaintiff has filed a new lawsuit against numerous defendants including IVC filter manufacturer C.R. Bard Inc. and Bard Peripheral Vascular Inc. alleging injuries sustained as a result of the G2 Vena Cava Filter.. The blood clot filter lawsuit accuses the defendants of manufacture and design negligence as well as failure to warn and breach of expressed and implied warranty.
If the body generates blood clots, the most common treatment options considered by doctors are the use of anticoagulants or blood thinners. These treatments, however, will not be an option for each patient.
IVC filters are one alternative way to prevent blood clot risks. These devices are placed in the biggest vein in the body, the inferior vena cava.
Blood clot filters like this were made commercially available in the early 1960s and various designs of them have been on the market since that time.
The primary purpose of an IVC filter is to capture blood clots that would travel from the lower parts of the body to the lungs and heart, potentially causing serious medical issues.
How Blood Clot Filters Are Meant to Work
If blood clots develop in the deep leg veins – a condition referred to as deep vein thrombosis – these can be considered pulmonary embolism by the time they reach the lungs and pose significant risks of death for the patients. Those individuals who have high risks for PE or DVT, have the option to undergo medical treatment in order to abate the risk.
According to the paperwork filed in the blood clot filter lawsuit however, some of the IVC filters on the market are extremely dangerous for patients. The retrievable IVC filter was first put on the market after Bard received FDA clearance in July of 2003.
Blood Clot Filter Lawsuit Basics
Numerous adverse event reports, as named in blood clot filter lawsuit, were associated with Bard’s retrievable IVC filters. An article published in the Annals of Surgery in 2015, for example, found that IVC filters were not effective in preventing PE. Nearly twice the number of patients with IVC filters in the study passed away, compared with those who had not received them and over five times the relative number of patients who received IVC filters ultimately developed DVTs.
The particular model mentioned in the blood clot filter lawsuit in regards the recovery filter manufactured by Bard, the company continued to market the filter model and keep it available to patients even after they received reports of serious injuries or death. In the newest blood clot filter lawsuit, C.R. Bard is accused of being aware of the risks but failing to warn doctors and patients about the catastrophic consequences of DVT and other significant side effects.
If you or someone you know has already suffered injuries from an IVC filter and want to talk to a lawyer about filing a blood clot filter lawsuit, contact the lawyers at McDonald Worley to learn more. The experienced IVC attorneys at McDonald Worley offer a FREE case evaluation. Call today!